By Top Class Actions  |  October 30, 2012

Category: Pharmaceuticals
{loadposition actos_lawsuit}
Follow us on Twitter and Facebook for the latest Actos Class Action Lawsuit & Settlement News!

 

Actos Bladder Cancer Cases Unlikely to Hurt Profits

By John Curran

 

Actos lawsuitHundreds of Actos bladder cancer lawsuit attorneys have filed claims on behalf of plaintiffs alleging that Takeda Pharmaceutical did not warn patients of the risk of Actos congestive heart failure side effects and other conditions caused by their drug. Don’t expect Takeda or the newly minted generic manufacturers who will sell the drug to worry too much.

The drug is simply too profitable, even with the risk of potentially deadly conditions. In 2009, according to recent court documents, Takeda made $3.4 billion in worldwide sales. While France has recently banned the sale of the diabetes drug because of Actos bladder cancer concerns, the market is still too great.

Further, the FDA fast-tracked the approval of the generic versions of Actos by three separate manufacturers for a six-month exclusivity period. In spite of the fact that generics are normally much less expensive, the generic firms like Mylan and Watson have one benefit. During the exclusivity period, they can charge prices very close to the brand-name price from Takeda.

Actos bladder cancer lawsuit attorneys will likely eventually file claims against them. By then, though, these companies will have created a cash cushion large enough to pay off most claimants in the case of a trial going to a jury award or being preempted by a settlement.

The rising population of Americans with Type 2 diabetes and taking the premier drug on the market assures that the companies will be just fine. Moreover, there has been a distinct lack of action by the FDA (they only recently added a warning for Actos bladder cancer risks in 2011) over the more than 10 years it’s been on the market.

Actos congestive heart failure lawsuit lawyers won’t have government documentation to support their case, and will instead focus on scientific studies to help clients.

If you or someone you know has taken the Type 2 diabetes drug and developed Actos bladder cancer conditions or other side effects, get educated. Visit our Actos Bladder Cancer Class Action Lawsuit Investigation now. There, you’ll be able to learn more about your options to pursue a claim against Takeda. Fill out the short form there to get a free consultation with an experienced Actos class action lawsuit attorney.

You may be able to get a settlement or jury award to help pay for the costs of surgery as well as rehabilitation. Learn whether or not your potential case could be successful and contact one of our partner Actos class action lawsuit attorneys today.

 

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

Updated October 30th, 2012

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2012 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.